Peptide vials organized on a clean surface with a dosing protocol notebook

You have read the basics. You understand what peptides are and you have seen the deep dive on recovery peptides. Now the question everyone lands on: "Can I combine them? And if so, how?"

The concept of "stacking" peptides -- running two or more compounds simultaneously -- is the most searched topic in the peptide space right now.[9] The "Wolverine Stack" (BPC-157 + TB-500) alone drove more search volume than any individual peptide compound in 2025. And with the February 2026 reclassification restoring legal compounding access for many of these compounds,[14][15] interest is only accelerating.

This guide covers three of the most commonly discussed beginner peptides -- BPC-157, TB-500, and Ipamorelin -- what each one does on its own, how people combine them, and the honest picture of what is supported by evidence versus what is community-derived speculation.

What Is Peptide Stacking?

"Stacking" simply means using two or more peptides at the same time. The idea comes from the same logic behind combination therapy in medicine: if two compounds target different pathways, combining them may produce broader or complementary effects.

Clean workspace with multiple labeled peptide vials and a protocol checklist

In the peptide world, the most common stacks pair a tissue repair peptide (like BPC-157 or TB-500) with a growth hormone secretagogue (like Ipamorelin or CJC-1295). The reasoning: repair the tissue directly while also boosting the body's natural growth hormone output to support recovery systemically.[10]

There is an important caveat upfront: no peptide stack has been studied as a combination in a controlled human trial.[11] Every stack protocol you encounter online is based on individual compound data combined with community-reported experience. That does not mean stacking is necessarily dangerous or ineffective. It means the evidence is incomplete, and you should approach it accordingly.

This article is for educational purposes. Peptide therapy should be pursued under medical supervision with compounds sourced from licensed compounding pharmacies. We do not recommend self-administering research chemicals purchased from unregulated suppliers.[12]

BPC-157: The Tissue Repair Peptide

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protein found in human gastric juice.[1] It is the single most discussed peptide in the recovery space, and for good reason: the preclinical evidence is extensive.

Close-up of a peptide vial labeled BPC-157 on a clinical surface

What the Research Shows

A 2025 systematic review in orthopaedic sports medicine synthesized the available data and confirmed effects across multiple tissue types:[3]

  • Tendon and ligament repair: Accelerated healing in Achilles tendon, MCL, and patellar tendon models. Increased collagen synthesis and organized fiber formation.[2][3]
  • Muscle healing: Faster recovery from muscle crush injuries in animal models.[3]
  • Gut protection: Protective effects against NSAID-induced gut damage, esophageal lesions, and inflammatory bowel models.[1] This is where BPC-157 gets its "body protection" name.
  • Angiogenesis: Promotes new blood vessel formation, which is critical for delivering oxygen and nutrients to injury sites.[4]

Why It Matters for Stacking

BPC-157's primary mechanisms -- angiogenesis, growth factor upregulation, and nitric oxide modulation[4] -- are largely focused on local tissue repair. This is why it pairs well with compounds that work through different pathways. It handles the repair work at the injury site while other peptides can address systemic recovery factors like growth hormone output or broad anti-inflammatory effects.

BPC-157 has zero completed human randomized controlled trials as of March 2026.[11] The animal data is compelling, but all human dosing protocols are extrapolated, not clinically validated.

TB-500: The Systemic Healer

TB-500 is a synthetic version of Thymosin Beta-4, a 43-amino-acid peptide found in virtually all human and animal cells.[5] Where BPC-157 tends to be associated with localized repair, TB-500 is known for systemic effects -- it does not just target one site.

What the Research Shows

  • Cell migration: TB-500 promotes the migration of endothelial cells and keratinocytes to injury sites.[6] This is the "get repair cells where they need to go" mechanism.
  • Actin regulation: Thymosin Beta-4 is a primary regulator of actin, a protein essential for cell structure and movement.[5] This is fundamental to how cells organize during healing.
  • Anti-inflammatory effects: Reduces inflammatory cytokines without suppressing the immune system entirely.[10]
  • Wound healing: Multiple studies show accelerated wound closure in animal models.[6]

Why It Matters for Stacking

TB-500's mechanisms -- actin regulation, cell migration, systemic anti-inflammatory effects -- are largely non-overlapping with BPC-157's angiogenesis and growth factor pathways.[5][4] This is the biological rationale behind the "Wolverine Stack": two compounds addressing different parts of the recovery cascade. BPC-157 creates the vascular infrastructure and growth signals. TB-500 mobilizes the cells and manages inflammation.

TB-500 has slightly more human-adjacent data than BPC-157 because Thymosin Beta-4 has been studied in clinical settings for wound healing and dry eye.[6] But for musculoskeletal recovery specifically, the data is still primarily from animal models.

Ipamorelin: The Growth Hormone Secretagogue

Ipamorelin is a growth hormone secretagogue -- it triggers your pituitary gland to release stored growth hormone (GH). Unlike exogenous GH injections, Ipamorelin preserves your body's natural pulsatile release pattern, which has a meaningfully different safety profile.[7]

Man sleeping in a dark bedroom with a clock showing nighttime

What the Research Shows

  • Selective GH release: Ipamorelin stimulates GH secretion without significantly raising cortisol or prolactin.[8] This selectivity is what makes it attractive compared to other GH secretagogues.
  • Pulsatile pattern: Because it works with your pituitary rather than replacing its function, GH is released in natural pulses -- primarily during deep sleep -- rather than as a constant elevation.[7]
  • Recovery support: Growth hormone drives tissue repair, muscle protein synthesis, fat metabolism, bone density, and sleep quality.[17] Boosting GH output naturally supports all of these.

Why It Matters for Stacking

Ipamorelin operates on a completely different axis than BPC-157 or TB-500. While those compounds work at the tissue level (repairing, migrating cells, building blood vessels), Ipamorelin works at the hormonal level -- telling your body to produce more of its own growth hormone. This is why it is frequently combined with tissue repair peptides: the theory is that elevated GH provides the systemic recovery environment while BPC-157 or TB-500 handles the targeted repair work.

Ipamorelin is most commonly paired with CJC-1295, a growth hormone releasing hormone (GHRH) analog. CJC-1295 tells the pituitary to produce more GH; Ipamorelin tells it to release what it has stored. Together they increase both production and release.[7]

Common Beginner Stacks

These are the combinations most frequently discussed in peptide communities and prescribed by peptide-literate clinicians. To be clear: "common" does not mean "clinically validated." These are protocols based on individual compound data, theoretical complementarity, and practitioner experience.

Three labeled peptide vials arranged with a written protocol sheet

1. The Wolverine Stack: BPC-157 + TB-500

The most popular peptide stack in existence.[9] Named after the Marvel character's regenerative abilities.

Protocol Overview

  • Target: Injury recovery, tendon/ligament healing, chronic joint issues
  • Rationale: Non-overlapping mechanisms -- BPC-157 (angiogenesis, growth factors) + TB-500 (cell migration, anti-inflammatory)[4][5]
  • Community-typical duration: 4-8 weeks
  • Administration: Subcutaneous injection, often near the injury site for BPC-157
  • Evidence level: Individual compounds have strong preclinical data. Combination has zero controlled studies.[10]

This is the stack most likely to be prescribed by a peptide clinic if you present with a nagging soft tissue injury that has not responded to rest and rehab. The biological logic is sound: two complementary repair pathways working in parallel. The limitation is that this remains a hypothesis, however well-reasoned.[11]

2. Recovery + GH: BPC-157 + TB-500 + Ipamorelin

The "full recovery stack" adds a growth hormone secretagogue to the Wolverine base.

Protocol Overview

  • Target: Accelerated injury recovery + systemic recovery support for men 40+
  • Rationale: Tissue repair (BPC-157 + TB-500) layered with GH optimization (Ipamorelin) for broader recovery support[17]
  • Timing: BPC-157/TB-500 typically administered in the morning; Ipamorelin before bed to align with natural GH release during sleep[7]
  • Evidence level: Each individual compound has supporting data. The three-way combination is purely theoretical.

This is a more aggressive protocol that some practitioners use for post-surgical recovery or persistent injuries in older patients where natural GH decline is a contributing factor. Adding Ipamorelin targets the hormonal environment that supports all recovery -- not just the local repair work.

3. GH Optimization: CJC-1295 + Ipamorelin

This is the most commonly prescribed growth hormone peptide combination and does not include a tissue repair peptide.

Protocol Overview

  • Target: Age-related GH decline, general recovery, sleep quality, body composition
  • Rationale: CJC-1295 stimulates GH production; Ipamorelin stimulates GH release. Together they increase both.[7]
  • Timing: Typically before bed, subcutaneous injection
  • Evidence level: CJC-1295 has human clinical data showing prolonged GH and IGF-1 elevation.[7] Ipamorelin has preclinical selectivity data.[8]

If your primary interest is general recovery optimization and body composition rather than healing a specific injury, this is the stack most practitioners start with. It has a cleaner evidence base than the tissue repair stacks because CJC-1295 actually has human trial data.[7]

How to Approach Stacking Safely

If you are considering peptide stacking, here is the framework that minimizes risk and maximizes useful information about how your body responds.

Doctor reviewing lab results with a patient in a modern clinic

1. Start with One Compound

This is the single most important rule. Do not start multiple peptides at the same time. If you start BPC-157, TB-500, and Ipamorelin simultaneously and feel better (or worse), you have no idea which compound is responsible. Run one compound for 2-4 weeks first. Track how you feel. Then add the second. This gives you a baseline for each.

2. Get Baseline Blood Work

Before starting any peptide protocol, get comprehensive blood work. At minimum: complete metabolic panel, CBC, IGF-1, fasting insulin, inflammatory markers (CRP, ESR), and a hormone panel if relevant. This gives you objective data to compare against, not just subjective feelings. Our guide to reading labs covers the key markers.

3. Work with a Prescriber

Find a physician who is knowledgeable about peptide therapy. This is not optional. You need someone who can write a prescription for a licensed compounding pharmacy, monitor your blood work, adjust dosing based on your response, and recognize complications if they arise.[16]

The February 2026 reclassification moved 14 peptides back to Category 1, restoring legal access through compounding pharmacies with a prescription.[14][15] There is no longer a regulatory barrier to getting these compounds through legitimate channels.

4. Source from Licensed Pharmacies

This cannot be overstated. A vial from a research chemical supplier labeled "BPC-157" might contain the correct compound, a degraded version, or something else entirely. Licensed compounding pharmacies operate under state pharmacy boards and must follow GMP standards.[12] The quality difference is not marginal -- it is fundamental.

5. Keep a Protocol Journal

Track everything: what you are taking, dosages, timing, injection sites, subjective energy, sleep quality, pain levels, and any side effects. This data is valuable for you and your prescriber. Without it, you are guessing. Our peptide database can serve as a reference for mechanisms and dosage ranges as you track your protocol.

6. Set a Time Limit

Most beginner protocols run 4-8 weeks for tissue repair peptides and 8-12 weeks for GH secretagogues. These are not meant to be taken indefinitely. Run a cycle, assess results with follow-up blood work, and decide whether to continue, adjust, or stop. Long-term safety data for most of these compounds is limited -- cycling reduces exposure and gives your body natural recovery periods.

Build your foundation first. If you are sleeping poorly, eating inadequately, or over-training, peptides will not compensate. Sleep, nutrition, stress management, and training load are still 90% of the equation. Peptides are the remaining 10% for people who have already optimized the basics. Read our sleep hygiene checklist and protein targets guide to make sure the foundation is solid.

What Not to Do

The peptide community is full of smart people sharing useful information. It also has significant blind spots. Here are the most common mistakes beginners make:

  • Do not stack more than 2-3 compounds at once. Some online protocols involve 5-6 peptides simultaneously. This is advanced territory with no research backing and makes it impossible to attribute effects (positive or negative) to any single compound.
  • Do not chase dosage from forum posts. A dose that works for a 200-pound athlete may be inappropriate for you. Dosing should be individualized with your prescriber based on your body weight, the condition being treated, and your response.[16]
  • Do not source from unregulated suppliers. The 2025 hospitalization incident at a longevity conference -- where two people ended up on ventilators after peptide injections -- is a concrete example of what happens when quality control fails.[12]
  • Do not use peptides if you are a competitive athlete subject to testing. BPC-157 and TB-500 are prohibited by WADA and USADA.[13] This is a career-ending violation regardless of your intent.
  • Do not expect miracles. Peptides are not steroids. They amplify your body's existing repair processes. If those processes are compromised because your sleep, nutrition, and training are poor, there is not much to amplify.
Self-administering injectable compounds without medical oversight carries real risks: infection, contamination, incorrect dosing, and missing contraindications that a physician would catch. This is not a supplement you pick up at a health food store. Treat it with appropriate seriousness.

The Bottom Line

Peptide stacking is a reasonable concept built on real biology. BPC-157, TB-500, and Ipamorelin each have meaningful preclinical evidence supporting their individual mechanisms. The logic of combining them -- targeting different aspects of the recovery cascade simultaneously -- is sound in theory.

But theory is not proof. No combination has been studied in a controlled human trial. Dosing protocols are community-derived, not clinically validated. Long-term safety data is limited for individual compounds and nonexistent for combinations.

If you are going to explore peptide stacking, do it intelligently: work with a prescriber, source from licensed pharmacies, start with one compound at a time, get baseline and follow-up blood work, and keep your expectations calibrated. Build your foundation first. Document everything. And remember that the most exciting part of the peptide space is what is coming -- human trials for BPC-157, AI-designed peptide sequences,[18] and personalized protocols based on individual biology.

The science is catching up. In the meantime, approach stacking with the respect it deserves: informed, cautious, and medically supervised.

References

  1. Seiwerth S, Sikiric P, Grabarevic Z, et al. BPC 157's effect on healing. J Physiol Paris. 1997;91(3-5):173-178. DOI
  2. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159. DOI
  3. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. PMC. Published 2025. Link
  4. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des. 2014;20(7):1126-1135. DOI
  5. Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-2151. DOI
  6. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. DOI
  7. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805. DOI
  8. Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008;149(9):601-611. DOI
  9. GlobeNewsWire. Wolverine Peptide Stack Inquiry Surges Ahead of 2026. Published November 25, 2025. Link
  10. GlobalRPH. BPC-157 and TB-500: Background, Indications, Efficacy, and Safety. Published November 2025. Link
  11. PolitiFact. What are peptides, and are they safe? Published March 6, 2026. Link
  12. MIT Technology Review. Peptides are everywhere. Here's what you need to know. Published February 23, 2026. Link
  13. USADA. BPC-157: Experimental Peptide Creates Risk for Athletes. Published 2025. Link
  14. Amanecia Health. FDA Peptide Reclassification 2026: What It Means for Patients. Published February 2026. Link
  15. Frier Levitt. FDA Peptide Regulation May Shift: What RFK Jr.'s Announcement Means for Compounding Pharmacies. Published February 2026. Link
  16. UPMC HealthBeat. What Is Peptide Therapy? Published January 2026. Link
  17. Murphy WJ, Rui H, Longo DL. Effects of growth hormone and prolactin on immune development and function. Life Sci. 1995;57(1):1-14. DOI
  18. Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309-325. DOI

Explore the Peptide Database

Detailed profiles for 50+ research peptides -- mechanisms, benefits, dosages, evidence levels, and linked studies from published research.

Recommended Products

Disclosure: This page contains affiliate links. As an Amazon Associate I earn from qualifying purchases. If you buy through these links, I may earn a commission at no extra cost to you. I only recommend products I personally use or have thoroughly researched.